View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

GL Events: 1 director

A director at GL Events sold 3,000 shares at 19.430EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

 PRESS RELEASE

Information regarding the total number of voting rights and total num...

Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024                                                                                                                                                                                                                                                                                                                  Information regarding the total number of voting rights and total number of shares of the Company as of March 31, 2024 (Article 223-16 of the General Regulations of the Au...

 PRESS RELEASE

Information relative au nombre total des droits de vote et d’actions ...

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2024 Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 mars 2024 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE Euronext Paris Code ISIN : FR 0010417345  Date  Nombre totald’actionscomposant le capital socialNombre totalde droits de vote31/03/2024 96 434 369  Total brut des droits de vote : 96 434 369  Total net* des droits de vote : 96 171 725  *Total net = nombre total de dro...

 PRESS RELEASE

1000mercis : Résultats annuels consolidés 2023

PARIS--(BUSINESS WIRE)-- Regulatory News: 1000mercis (FR0010285965 – ALMIL), spécialiste du Data Marketing, annonce ses résultats annuels consolidés au 31 décembre 2023. En millions d'euros 31.12.2023 31.12.2022 Var. Chiffre d'affaires 72,8 76,9 -4,1 Variation 2023/ 2022 -5%     Résultat d'exploitation 3,5 1,5 2 Marge d'exploitation 5% 2%   Résultat financier -1,7 -0,6   Résultat exceptionnel 0,7 0,4   Résultat net part du groupe 3,3 2,2 1,1 Le chif...

Robin Leclerc (IDMidCaps)
  • Robin Leclerc (IDMidCaps)

GL events - Remarkable performance but still room for improvement

Historic 2023 results, slightly better than expectedOMC has almost reached an all-time high, although there are still areas where the recovery is not complete.Balance sheet ratios have improved and debt is fully sustainable2024 growth target likely to be exceededThe year will continue to be marked by a heavy investment program, which will limit debt reductionOpinion raised to Buy to take advantage of favorable newsflow and reasonable valuation

Nicolas David ... (+2)
  • Nicolas David
  • Nicolas Thorez

ODDO : Accenture voit une reprise plus limitée qu’attendu pour son T3 ...

>Croissance T2 flat à cc, légèrement inférieure aux attentes - Accenture a publié hier avant l’ouverture de la Bourse US, ses résultats T2 2024 (trimestre clos à fin février). La croissance ressort flat y/y à cc, en ligne avec le milieu de fourchette de sa guidance (-2% à 2% y/y à cc) mais légèrement en-dessous des attentes (+0.7% y/y à cc). Il s'agit d'un nouveau ralentissement par rapport au T1 2024 (+1% à cc). Ce ralentissement est notamment lié au déclin des acti...

Nicolas David ... (+2)
  • Nicolas David
  • Nicolas Thorez

ODDO : Accenture sees a more limited recovery than expected for its FY...

>Q2 growth flat at cc, a shade below forecasts - Yesterday before trading started on the US market, Accenture reported its Q2 2024 earnings (quarter to end-February). Growth was flat y-o-y at constant currency, in line with the middle of the guidance range (-2% to 2% y-o-y at cc) but a shade below forecasts (+0.7% y-o-y at cc). This was a fresh slowdown relative to Q1 2024 (+1% at cc). This slowdown is due notably to the downturn in the operations activities, with a ...

Denis Scherrer (IDMidCaps)
  • Denis Scherrer (IDMidCaps)

Infotel - A little more patience before growth returns

2023 results slightly below our expectationsEBIT margin (before the cost of bonus shares) deteriorated further in H2 (8.6% vs. 9.2% in H1), although it remains at a good levelLike other IT Services sectors with high exposure to the banking sector, Infotel's growth has stalled since Q2, which has logically weighed on profitabilityQ1 will see a further decline, given the high basis for comparisonDemand remains solid, however, and business in 2024 is expected to grow, with profitability improv...

Benoit Valleaux ... (+3)
  • Benoit Valleaux
  • Steven Gould
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 03/14/2024

Banks tick all the boxes in the market’s current configuration: search for discounted sectors, cyclical momentum, sectors driven by long-term interest rates that remain high and shareholder returns through very high dividend yields. Technical analysis reveals a strong conviction since early March, and this should continue. We prefer banks in southern Europe, where the macro outlook is brighter. Alongside CaixaBank, which we are maintaining in our list of European Large Cap stocks, we ...

Jerôme Bodin ... (+2)
  • Jerôme Bodin
  • Thomas Zlowodzki

ODDO BHF Small & MIDCAP MORNING NEWS - 14/03/2024

Les banques cochent toutes les cases de la configuration de marché actuelle : recherche de secteurs décotés, momentum cyclique, secteurs portés par des taux longs qui restent hauts, retour à l’actionnaire via un très haut dividend yield. L’analyse technique montre une forte conviction depuis début mars, qui devrait se poursuivre. Nous favorisons les banques du sud de l’Europe, à la macro plus avenante. Aux côtés de CaixaBank, que nous conservons dans notre liste de valeurs Large Caps ...

Nicolas Thorez
  • Nicolas Thorez

Infotel : 2023 results in line. Recovery in business still seen in H2

>Contraction in 2023 earnings but broadly speaking close to expectations - Infotel reported 2023 results that were broadly in line with our expectations. On full-year sales (already reported) of € 307.5m, showing organic growth of 2.4%, underlying EBIT came to € 27.5m excluding free share allocation costs, down -7.7% (vs ODDO BHF estimate € 27.9m). This points to an adjusted underlying operating margin of 8.9% (excluding free share allocations), or a fall of 100 bp y-...

Nicolas Thorez
  • Nicolas Thorez

Infotel : Résultats 2023 conformes. Rebond de l’activité toujours envi...

>Des résultats 2023 en contraction mais globalement proches des attentes - Infotel a publié des résultats 2023 globalement conformes à nos attentes. Pour un CA FY (déjà publié) de 307.5 M€, en croissance de 2.4% org, l’EBIT courant s’affiche à 27.5 M€ hors coût des actions gratuites, en retrait de 7.7% (vs ODDO BHF 27.9 M€). Ceci fait ressortir une MOC ajustée de 8.9% (hors AGA), soit un retrait de 100 pb y-o-y, et de 8.1% en incluant le coût des actions gratuites (vs...

Eurofins Scientific S.E: 1 director

A director at Eurofins Scientific S.E sold 400 shares at 54.720EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

DBV Technologies SA: 1 director

A director at DBV Technologies SA bought 34,188 shares at 0.861USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

DBV Technologies announces filing of 2023 Annual Report on Form 10-K a...

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document Montrouge, France, March 8, 2024 DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “Company”), today announced the filing, for the year ended December 31, 2023, of its Annual Report on F...

 PRESS RELEASE

DBV Technologies publie son « Form 10-K » américain et son Document d’...

DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023 Montrouge, France, le 8 mars 2024 DBV Technologies publie son « Form 10-K » américain et son Document d’Enregistrement Universel 2023 DBV Technologies (Euronext : DBV – ISIN : FR0010417345 - Nasdaq : DBVT), une société biopharmaceutique au stade clinique (la « Société »), a annoncé aujourd'hui que son « Form 10-K » 2023 avait été déposé auprès de la Securities and Exchange Commission (« SEC ») aux Etats-Unis ainsi que son document d’enregistrement universel 2023 (« DEU »), auprès de l’Autor...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch